Lima, M. D., Sanchez-Petitto, G., Waller, E., Craddock, C., Calbacho, M., Fatobene, G., Ghali, D., Rubel, J., Oehen, S., Hasskarl, J. (2025). MO-TRANS update: A randomized, double-blind, placebo-controlled, multi-center phase III study of mocravimod (MOC) as maintenance treatment in AML patients undergoing allogeneic hematopoietic cell transplantation. Blood. https://doi.org/10.1182/blood-2025-6086